Labile glycated hemoglobin: an underestimated laboratory marker of short term glycemia

Joris R Delanghe1, Stijn Lambrecht1, Tom Fiers1

  • 1Department of Clinical Chemistry, Ghent University Hospital, Ghent, Belgium.

Insights

Labile hemoglobin A1c (l-HbA1c) offers a faster indicator for glycemic changes than standard HbA1c. This labile fraction, alongside red blood cell distribution width (RDW), aids in monitoring diabetes management.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Hematology

Background:

  • Diabetes mellitus poses a significant public health challenge.
  • Hemoglobin A1c (HbA1c) is crucial for diabetes management but has limitations due to red blood cell (RBC) lifespan variations and slow response to glucose changes.
  • A labile HbA1c (l-HbA1c) fraction exhibits faster kinetics and can be measured alongside HbA1c.

Purpose of the Study:

  • To explore the utility of the l-HbA1c fraction for monitoring glycemia.
  • To assess the correlation of l-HbA1c with glycemic control and HbA1c.
  • To investigate the relationship between l-HbA1c, HbA1c, and red blood cell distribution width (RDW).

Main Methods:

  • Simultaneous assay of l-HbA1c and HbA1c fractions using a Tosoh G8 analyzer.
  • Comparison of l-HbA1c results with serum glucose and HbA1c.
  • Determination of RDW using a Sysmex SN analyzer to assess erythrocyte lifespan.

Main Results:

  • l-HbA1c demonstrated good measurement precision (CVs 2.2-2.3%).
  • l-HbA1c showed strong correlations with glycemia (r=0.80) and HbA1c (r=0.73).
  • Glycemia and HbA1c were the primary determinants of l-HbA1c in a multiple regression model (r²=0.752); RDW showed a weaker correlation.

Conclusions:

  • l-HbA1c serves as an additional marker for detecting rapid glycemic fluctuations missed by standard HbA1c and blood glucose monitoring.
  • RDW can indicate atypical RBC lifespan, potentially enhancing the interpretation of l-HbA1c fraction results.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
369
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
291
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
389
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
967
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.1K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.5K